Studies have shown that activating the JAK-STAT3 pathway enhances migration (Okitsu et al., 2010), drug resistance, proliferation (Zhang et al., 2017), and stemness (Alcalá et al., 2019) of pancreatic cancer cells. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.